Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed COO
Appointed director
Notes underwriting agrmnt
|
|
Xenetic Biosciences, Inc. (XBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/21/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/21/2020 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 0% stake in Xenetic Biosciences, Inc. |
| 09/04/2019 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 5.1% stake in Xenetic Biosciences, Inc. |
| 08/07/2019 |
SC 13G
| CVI Investments, Inc. reports a 8.9% stake in Xenetic Biosciences, Inc. |
| 07/29/2019 |
SC 13G
| Anson Funds Management LP reports a 9.8% stake in Xenetic Biosciences, Inc. |
| 07/25/2019 |
SC 13G
| Altium Capital Management LP reports a 9.8% stake in Xenetic Biosciences, Inc. |
| 03/11/2019 |
SC 13G
| Empery Asset Management, LP reports a 10% stake in Xenetic Biosciences, Inc. |
|
|